116349004: Gatifloxacin (substance)

SNOMED CT Concept\Substance\...

\Substance categorized by disposition\Antibacterial\Quinolone antibacterial\Fluoroquinolone (substance)\Gatifloxacin

\A grouper concept for substances that are used in medicinal products for medical treatment, and also psychoactive substances that have few or no legitimate medical uses or that are not legally available to the person using them.\Anti-infective agent (substance)\Antibacterial\Quinolone antibacterial\Fluoroquinolone (substance)\Gatifloxacin
\A grouper concept for substances that are used in medicinal products for medical treatment, and also psychoactive substances that have few or no legitimate medical uses or that are not legally available to the person using them.\Quinoline\Quinolone (substance)\Quinolone antibacterial\Fluoroquinolone (substance)\Gatifloxacin

\Substance categorised by structure\Chemical\Chemical categorized by structure (substance)\...

\Nitrogen and/or nitrogen compound (substance)\Nitrogen compound\Organic nitrogen compound\Amine and/or amine derivative\Quinoline\Quinolone (substance)\Quinolone antibacterial\Fluoroquinolone (substance)\Gatifloxacin

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module

177274013 Gatifloxacin en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

677592014 Gatifloxacin (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

4756961000241117 gatifloxacine fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Gatifloxacin	Is a	Medicinal product containing quinolone and acting as antibacterial agent (product)	false	Inferred relationship	Some
Gatifloxacin	Is a	Quinolone antibacterial	false	Inferred relationship	Some
Gatifloxacin	This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context.	Antibacterial (disposition)	true	Inferred relationship	Some
Gatifloxacin	Is a	Fluoroquinolone (substance)	true	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Product containing gatifloxacin (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Gatifloxacin	Inferred relationship	Some	1
Gatifloxacin 400 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Gatifloxacin	Inferred relationship	Some
Gatifloxacin 10mg/mL injection solution 20mL vial	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Gatifloxacin	Inferred relationship	Some
Gatifloxacin 2mg/mL infusion solution 100mL bag	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Gatifloxacin	Inferred relationship	Some
Gatifloxacin 2mg/mL infusion solution 200mL bag	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Gatifloxacin	Inferred relationship	Some
Gatifloxacin 200 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Gatifloxacin	Inferred relationship	Some
Gatifloxacin 200mg/vial solution	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Gatifloxacin	Inferred relationship	Some
Gatifloxacin 400mg/vial solution	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Gatifloxacin	Inferred relationship	Some
Product containing gatifloxacin in oral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Gatifloxacin	Inferred relationship	Some	1
Gatifloxacin-containing product in parenteral dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Gatifloxacin	Inferred relationship	Some	1
Zymar	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Gatifloxacin	Inferred relationship	Some
Product containing precisely gatifloxacin 3 milligram/1 milliliter conventional release eye solution (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Gatifloxacin	Inferred relationship	Some
Zymar 0.3% ophthalmic solution	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Gatifloxacin	Inferred relationship	Some
Product containing precisely gatifloxacin 40 milligram/1 milliliter conventional release oral suspension (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Gatifloxacin	Inferred relationship	Some
Product containing gatifloxacin in ophthalmic dosage form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Gatifloxacin	Inferred relationship	Some
Gatifloxacin 5 mg/mL eye solution	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Gatifloxacin	Inferred relationship	Some
Gatifloxacin 400 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Gatifloxacin	Inferred relationship	Some	1
Gatifloxacin 400 mg oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Gatifloxacin	Inferred relationship	Some	1
Gatifloxacin 200 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Gatifloxacin	Inferred relationship	Some	1
Gatifloxacin 200 mg oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Gatifloxacin	Inferred relationship	Some	1
Gatifloxacin 200 mg oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Gatifloxacin	Inferred relationship	Some	1
Gatifloxacin 400 mg oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Gatifloxacin	Inferred relationship	Some	1
Product containing gatifloxacin in ocular dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Gatifloxacin	Inferred relationship	Some	1
Gatifloxacin only product	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Gatifloxacin	Inferred relationship	Some	1
Gatifloxacin only product in ocular dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Gatifloxacin	Inferred relationship	Some	1
Product containing only gatifloxacin in oral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Gatifloxacin	Inferred relationship	Some	1
Product containing only gatifloxacin in parenteral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Gatifloxacin	Inferred relationship	Some	1
Product containing precisely gatifloxacin 3 milligram/1 milliliter conventional release eye solution (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Gatifloxacin	Inferred relationship	Some	1
Product containing precisely gatifloxacin 3 milligram/1 milliliter conventional release eye solution (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Gatifloxacin	Inferred relationship	Some	1
Gatifloxacin 5 mg/mL eye solution	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Gatifloxacin	Inferred relationship	Some	1
Gatifloxacin 5 mg/mL eye solution	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Gatifloxacin	Inferred relationship	Some	1
Product containing precisely gatifloxacin 40 milligram/1 milliliter conventional release oral suspension (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Gatifloxacin	Inferred relationship	Some	1
Product containing precisely gatifloxacin 40 milligram/1 milliliter conventional release oral suspension (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Gatifloxacin	Inferred relationship	Some	1

Reference Sets

GB English

US English

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
177274013	Gatifloxacin	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
677592014	Gatifloxacin (substance)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
4756961000241117	gatifloxacine	fr	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module